ArticleCase reports in oncology

Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor.

Corey A Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.